Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dihydrofolate reductase | Starlite/ChEMBL | References |
Neisseria gonorrhoeae | Dihydrofolate reductase | Starlite/ChEMBL | References |
Plasmodium berghei | bifunctional dihydrofolate reductase-thymidylate synthase, putative | Starlite/ChEMBL | References |
Homo sapiens | dihydrofolate reductase | Starlite/ChEMBL | References |
Escherichia coli | Dihydrofolate reductase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0567 | 0.377 | 0.377 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0963 | 0.8485 | 0.5 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.109 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0816 | 0.6745 | 0.7949 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.109 | 1 | 1 |
Echinococcus multilocularis | caspase 2 | 0.0816 | 0.6745 | 0.6745 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Brugia malayi | dihydrofolate reductase family protein | 0.0963 | 0.8485 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Echinococcus multilocularis | caspase 3 | 0.0523 | 0.3255 | 0.3255 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0567 | 0.377 | 0.5 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0579 | 0.3925 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0567 | 0.377 | 0.4443 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0579 | 0.3925 | 1 |
Brugia malayi | Cell death protein 3 precursor | 0.0816 | 0.6745 | 0.7949 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0579 | 0.3925 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0567 | 0.377 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0567 | 0.377 | 0.5 |
Echinococcus granulosus | caspase 8 | 0.0567 | 0.377 | 0.377 |
Echinococcus multilocularis | caspase | 0.109 | 1 | 1 |
Echinococcus granulosus | caspase 2 | 0.0816 | 0.6745 | 0.6745 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0567 | 0.377 | 0.5 |
Echinococcus multilocularis | caspase 8 | 0.0567 | 0.377 | 0.377 |
Brugia malayi | Dihydrofolate reductase | 0.0963 | 0.8485 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0816 | 0.6745 | 1 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0963 | 0.8485 | 0.5 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0567 | 0.377 | 0.4443 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Schistosoma mansoni | dihydrofolate reductase | 0.0963 | 0.8485 | 0.8485 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Echinococcus granulosus | caspase 3 | 0.0523 | 0.3255 | 0.3255 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0963 | 0.8485 | 0.8485 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0963 | 0.8485 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Echinococcus granulosus | caspase | 0.109 | 1 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0963 | 0.8485 | 0.5 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.109 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0567 | 0.377 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0567 | 0.377 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0579 | 0.3925 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0963 | 0.8485 | 1 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0816 | 0.6745 | 0.6745 |
Echinococcus granulosus | dihydrofolate reductase | 0.0963 | 0.8485 | 0.8485 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0567 | 0.377 | 0.5 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0579 | 0.3925 | 1 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0579 | 0.3925 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
I50 (binding) | = 60000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) from Escherichia coli | ChEMBL. | 3100802 |
I50 (binding) | = 150000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei | ChEMBL. | 3100802 |
I50 (binding) | = 490000000 M | Inhibition of N. gonorrhoeae Dihydrofolate reductase(DHFR) | ChEMBL. | 3121854 |
I50 (binding) | = 490000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Neisseria gonorrhoea | ChEMBL. | 3100802 |
I50 (binding) | = 44500000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) from rat liver | ChEMBL. | 3100802 |
IC50 (binding) | = 0.000000006 M | Inhibitory activity against dihydrofolate reductase (DHFR) from Escherichia coli | ChEMBL. | 3100802 |
IC50 (binding) | = 0.000000015 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei | ChEMBL. | 3100802 |
IC50 (binding) | = 0.000000049 M | Inhibition of N. gonorrhoeae Dihydrofolate reductase(DHFR) | ChEMBL. | 3121854 |
IC50 (binding) | = 0.000000049 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Neisseria gonorrhoea | ChEMBL. | 3100802 |
IC50 (binding) | = 0.00000445 M | Inhibitory activity against dihydrofolate reductase (DHFR) from rat liver | ChEMBL. | 3100802 |
MIC (functional) | = 0.3 ug ml-1 | Inhibition of growth of Staphylococcus aureus (CN491) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 0.3 ug ml-1 | Inhibition of growth of serratia marcescens (CN2398) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 1 ug ml-1 | Inhibition of growth of Vibrio cholera (ATCC14035) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 3 ug ml-1 | Inhibition of growth of Mycobacterium smegmatis (S3254) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 3 ug ml-1 | Inhibition of growth of Salmonella typhi (CN512) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 3 ug ml-1 | Inhibition of growth of Shigella flexneri (CN6007) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 3 ug ml-1 | Inhibition of growth of Klebsiella pneumoniae (CN3632) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 3 ug ml-1 | Inhibition of growth of Proteus vulgaris (CN329) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 10 ug ml-1 | Inhibition of growth of Escherichia coli (CN314) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 10 ug ml-1 | Inhibition of growth of Enterobacter aerogenes(2200/186) measured as MICcompound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 10 ug ml-1 | Inhibition of growth of Escherichia coli (CN314) measured as MIC compound/MIC Trimethoprim | ChEMBL. | 3121854 |
MIC (functional) | = 9 uM | Inhibition of growth of Neisseria gonorrhoeae | ChEMBL. | 3121854 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.